Analyst firms · Jefferies · IBM

Jefferies IBM price target and rating history

International Business Machines Corporation (IBM) · Technology

Jefferies rates International Business Machines Corporation (IBM) Buy with a $360 price target, as of its latest action on Jan 5, 2026. It has published 3 rating actions on IBM since October 2021, including 1 upgrade and 0 downgrades. Across 11 firms with a IBM price target in the last 12 months, the median target is $295. Jefferies's $360 is 22% above that.

Current rating
Buy
Price target
$360
Median target, all firms
$295
Actions on IBM
3

Jefferies price target on IBM

$360$265$17020222023202420252026
Jefferies price target on IBM, each point a stated target, October 2021 to January 2026.

Every Jefferies rating on IBM

How other firms rate IBM

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Truist SecuritiesHold$240Oct 9, 2026
Robert W. BairdNeutral$230Jul 22, 2026
OppenheimerPerform$360Jul 15, 2026
HSBCReduce$191Jul 14, 2026
SusquehannaNeutral$303Jul 10, 2026
BarclaysOverweight$350Jun 1, 2026
DZ BankBuy$295Apr 24, 2026
CitigroupBuy$285Apr 10, 2026
UBSNeutral$236Feb 25, 2026
Erste GroupHoldFeb 18, 2026
Evercore ISIOutperform$330Jan 20, 2026
JefferiesBuy$360Jan 5, 2026

Questions about Jefferies and IBM

What is Jefferies's price target for IBM?
Jefferies's latest stated price target for International Business Machines Corporation (IBM) is $360, from its action on Jan 5, 2026.
What is Jefferies's rating on IBM?
Jefferies rates IBM Buy, a bullish rating, as of Jan 5, 2026.
When did Jefferies last change its view on IBM?
On Jan 5, 2026, Jefferies upgrades to Buy from Hold, price target $360.
How does Jefferies's IBM target compare with other analysts?
Across 11 firms with a IBM price target in the last 12 months, the median target is $295. Jefferies's $360 is 22% above that.

More IBM rating histories

All Jefferies ratingsIBM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.